YouTube video by IBTV
Saisei Ventures' Sven Kili talks to IBTV at ARM / Cell & Gene's Meeting on the Mesa 2025
@biosurgerysven.bsky.social and Sonny Dhawan had an exciting time at ARM's 2025 Cell & Gene Meeting on the Mesa!
Sven spoke with IBTV to share some highlights from the meeting, and reflected on ARM’s continued dedication to patient advocacy.
www.youtube.com/watch?v=K12G...
#CGMesa25
21.10.2025 14:36 — 👍 0 🔁 0 💬 0 📌 0
The BioHub - The Avetix Podcast - S2 Ep71 - Nick Manusos - CEO of Kenai Therapeutics
Welcome back to another episode of The BioHub, we were delighted to welcome on Nick Manusos, the CEO of Kenai Therapeutics, a pioneering biotech company developing neuron replacement therapies for neurological disorders. Nick’s journey spans decades of innovation and leadership—from senior roles at global pharma giants like Baxter, Takeda, and Abbott, to founding and leading cutting-edge startups like Iota Biosciences and Opsis Therapeutics. Under his guidance, Kenai Therapeutics has secured groundbreaking funding and is advancing life-changing therapies for patients with Parkinson’s disease. He holds an MBA from Northwestern University’s Kellogg School of Management and a BBA from the University of Wisconsin, bringing a rare combination of business acumen and scientific vision to the table. Nick joins us today to share his insights on pioneering stem cell therapies, building biotech startups from the ground up, and what it takes to turn cutting-edge science into real-world solutions.
Kenai Therapeutics is on a mission to cure neurological conditions like #Parkinsons using #celltherapies. Nick Manusos, CEO of Kenai, joined The Bio Hub to share his path to Kenai, and the lessons he learned along the way. #SaiseiPortCo @kenaitx.bsky.social
Listen here: bit.ly/42aLMSY
25.09.2025 14:58 — 👍 1 🔁 0 💬 0 📌 0
#AdvancedTherapiesEurope challenged us to think differently about how to scale advanced therapies and bring them to patients faster. @biosurgerysven.bsky.social and Miguel Forte came away feeling energized by the work the community is doing. We can’t wait to be back next year! #ATE25
16.09.2025 19:24 — 👍 0 🔁 0 💬 0 📌 0
日本の製薬業界において20年以上のリーダーシップ経験を持つ、ジェームズ・フェリシアーノ氏のベンチャーパートナー就任を歓迎します!サイセイでは、ポートフォリオ企業と共に開発戦略の立案を支援します。詳細はこちら:http://bit.ly/4ppZScX
15.09.2025 22:02 — 👍 0 🔁 0 💬 0 📌 0
We’re excited to welcome James Feliciano as a venture partner! With 20+ years of pharma leadership experience in #Japan, he will help guide development strategies alongside our portfolio companies. Learn more: bit.ly/4ppZScX
15.09.2025 13:01 — 👍 1 🔁 0 💬 0 📌 0
Congrats to our intern, Siwei Huang, on her research presentation! Siwei is an MSc student at #UCL, and her research involved creating an AI Usage Scale to measure how meaningfully companies are using #AI and #ML in the #drugdevelopment process.
12.09.2025 15:00 — 👍 1 🔁 0 💬 0 📌 0
Managing Partner @jonathanyeh.bsky.social joined fellow #biotech and #VC experts at the #AsiaBioPartneringForum! His session focused on the future of biotech investing in Asia, where panelists provided insights into how companies can successfully navigate regulatory and funding shifts.
11.09.2025 17:33 — 👍 0 🔁 0 💬 0 📌 0
What will it take to unlock the full potential of #GeneEditing?
In the latest issue of Cell & Gene Therapy Insights,
@biosurgerysven.bsky.social examines the gene editing landscape and shares his perspective on how to bring lasting impact to patients.
Read the full issue here: bit.ly/464OE4S
05.09.2025 21:08 — 👍 0 🔁 0 💬 0 📌 0
Sven Kili is in Barcelona this week for #AdvancedTherapiesEurope!
He joined biotech industry experts to discuss the fundraising landscape for #CGT startups, bringing a unique perspective as both an investor and clinician.
Thanks to Phacilitate for organizing! #ATE25 @biosurgerysven.bsky.social
03.09.2025 15:00 — 👍 0 🔁 0 💬 0 📌 0
Who really funds global #DrugDevelopment?
Jonathan Yeh, Managing Partner at Saisei, discusses how the future of healthcare innovation depends on contributions from the entire global ecosystem, rather than a single market.
Read more: bit.ly/477CSc7
21.08.2025 13:02 — 👍 0 🔁 0 💬 0 📌 0
We’re thrilled to partner with Japan’s #MHLW on the new Drug Discovery Ecosystem Development Support Project!
This program will connect #biotech startups with world-class experts in order to advance their discoveries and help make an impact for patients worldwide.
Learn more: bit.ly/3Jj0r82
18.08.2025 12:30 — 👍 0 🔁 0 💬 0 📌 0
At #Expo2025Osaka - a global event dedicated to “Designing Future Society for Our Lives” - #SaiseiPortCo United Immunity’s breakthrough platform was named UCB Pharma’s “Most Innovative Technology with Potential for Disruption.” Congrats to President Masato Kishida & team on this incredible honor!
26.06.2025 14:01 — 👍 0 🔁 0 💬 0 📌 0
Congrats to @biosurgerysven.bsky.social and cofounders Michelle Boxall and Lee Buckler on launching Advanced Therapies Think Tank - #AT3, a new platform for unfiltered discussions on the advancement of cell & gene therapies. Season 1 starts July 3!
Learn more: www.advancedtherapiesthinktank.com
18.06.2025 15:30 — 👍 1 🔁 1 💬 0 📌 0
The #ASCO2025 Annual Meeting is here! Sonny Dhawan, PhD, is in Chicago and excited to meet with colleagues and partners to discuss the future of #oncology.
31.05.2025 19:28 — 👍 1 🔁 0 💬 0 📌 0
The rise of #entrepreneurship is quietly reshaping Japan’s workforce.
In a new article, Jonathan Yeh, Managing Partner, shares his perspective on how a new generation is breaking from tradition to embrace #startups and #innovation. Read more: bit.ly/4kGenXa
28.05.2025 14:53 — 👍 0 🔁 0 💬 0 📌 0
Our team is in New Orleans for #ASGCT2025! Excited to connect with innovators and explore the latest in cell & gene therapy. Researchers-let’s chat! Message us here or find Yusuke Wada, Ph.D. or Sonny Dhawan, Ph.D. between sessions. Hope to see you there! @asgct.bsky.social
13.05.2025 15:14 — 👍 0 🔁 0 💬 0 📌 0
Saisei が行っている次世代リーダー育成プログラム "Executive Fellows Program" のメンター、Audrey GreenbergさんとMiguel Forteさんが、The Medicine Maker 2025 #PowerList に選出されました!
グローバルリーダーとしてのご実績、おめでとうございます!
受賞者一覧はこちら bit.ly/4m3AGHK
05.05.2025 00:24 — 👍 1 🔁 0 💬 0 📌 0
Congratulations to Audrey Greenberg and Miguel Forte, our Executive Fellow Mentors, on being named to The Medicine Maker 2025 #PowerList! A well-deserved honor for two inspiring leaders. See the full list here: bit.ly/4m3AGHK
05.05.2025 00:23 — 👍 1 🔁 1 💬 0 📌 0
Congratulations to the #Craif team on their Series C financing! Craif is a molecular diagnostic company focused on #EarlyCancerDetection by analyzing a patient's microRNA.
Learn more: craif.com/en/20250428-...
#SaiseiPortCo
28.04.2025 21:00 — 👍 1 🔁 0 💬 0 📌 0
Saisei Ventures は、今年11月開催の #Science2StartupJapanに協賛します!S2S Japanは、トップ研究者とグローバルな投資家、製薬企業を結びつけ、#バイオテック #イノベーションを推進し、日本のライフサイエンスエコシステムを強化することを目的としたイベントです。応募は5/9まで!詳細・応募はこちら:https://s2s-japan.com/en/ #S2SJapan
25.04.2025 17:49 — 👍 0 🔁 0 💬 0 📌 0
We're a proud sponsor of #Science2StartupJapan! S2S Japan aims to enhance Japan's life sciences ecosystem by connecting top researchers with global investors, pharmaceutical companies to advance #biotech #innovation. Apply by May 9 to join the class of 2025: s2s-japan.com/en/ #S2SJapan
25.04.2025 17:48 — 👍 0 🔁 0 💬 0 📌 0
We're in Rome for the Cell & Gene Meeting on the Mediterranean! Join @biosurgerysven.bsky.social as he moderates a panel discussion on the dynamic ATMP investment landscape.
Date: Wednesday, April 16
Time: 10:45 AM
Location: Salone dei Cavalieri, Section 3&4
Full agenda: bit.ly/42kLqs1
#CGMed25
10.04.2025 15:53 — 👍 1 🔁 1 💬 0 📌 0
Saisei Ventures Announces the Appointment of Dr. Sven Kili, MD, as Partner
Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations, announced today that Dr. Sven Kili
Dr. Sven Kili has been appointed partner at Saisei! Having advised the firm since its inception, he is now full-time, bringing over 20 years of experience in clinical practice and pharmaceutical leadership. Join us in welcoming Dr. Kili to his new role! bit.ly/4gOtZWM
@biosurgerysven.bsky.social
09.01.2025 14:02 — 👍 2 🔁 1 💬 1 📌 1
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
New England's leading source for breaking news and analysis.
bostonglobe.com
The best of business since 1930.
In-depth, independent reporting to better understand the world, now on Bluesky. News tips? Share them here: http://nyti.ms/2FVHq9v
Pioneering next generation approaches to cure neurological conditions. https://www.kenaitx.com/
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
Journalist covering intersection of pharma, health policy & politics for the Pink Sheet.
On Signal at SarahKarlinSmith.34
KFF Health News’ ‘What The Health?’ panelist.
Co-created Prescription PULSE at Politico.
GWU alum, dabbled in SMPA adjunct-ness.
Can you can block people here?
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky
Priors: Bloomberg News + the Covid vaccine tracker. CQ.
Reporting from the frontiers of health & medicine.
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
Founder & Editor, Timmerman Report.
Longtime biotech observer and news guy who created FierceBiotech and founded Endpoints News, which now has more than 200,000 subscribers clustered in the biopharma business. (I also have a thing for agave.)
Surgeon, VC and strategic consultant experienced in developing Cell & Gene Therapies. When not trail running do a little traveling too....
official Bluesky account (check username👆)
Bugs, feature requests, feedback: support@bsky.app